These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 7961551)

  • 21. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR
    Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL; Wagner RL
    J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current data on neurologic sequelae caused by neuroleptics].
    Krebs MO
    Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
    Tarsy D; Baldessarini RJ
    Mov Disord; 2006 May; 21(5):589-98. PubMed ID: 16532448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects.
    Peacock L; Solgaard T; Lublin H; Gerlach J
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):188-96. PubMed ID: 8935815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome.
    Shirzadi AA; Ghaemi SN
    Harv Rev Psychiatry; 2006; 14(3):152-64. PubMed ID: 16787887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesia.
    Casey DE
    J Clin Psychiatry; 1998; 59 Suppl 3():31-7. PubMed ID: 9541336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pisa syndrome in clozapine therapy].
    Kurtz G; Kapfhammer HP; Peuker B
    Nervenarzt; 1993 Nov; 64(11):742-6. PubMed ID: 8278016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of clozapine on treatment-resistant akathisia and concomitant tardive dyskinesia.
    Wirshing WC; Phelan CK; van Putten T; Marder SR; Engel J
    J Clin Psychopharmacol; 1990 Oct; 10(5):371-3. PubMed ID: 1979566
    [No Abstract]   [Full Text] [Related]  

  • 35. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
    Gerlach J
    J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Iatrogenic extrapyramidal disorders].
    Ludin HP
    Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects.
    Kim JH; Byun HJ
    Clin Neuropharmacol; 2003; 26(6):312-6. PubMed ID: 14646611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of 15 patients with tardive dystonia.
    Sachdev P
    Am J Psychiatry; 1993 Mar; 150(3):498-500. PubMed ID: 8094600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR; McPhillips MA
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.